Financial documents

File name Publication date Link
Generix Group - Q1 2022/2023 REVENUES: €20.9M New SaaS contracts Q1 2022/2023: €1.2m Growth in SaaS revenues: 11% 26-07-2022
Provision of the draft information memorandum 16-06-2022
Acquisition of shares by New Gen Holding through contributions in kind and purchase of shares from minority financial shareholders of Generix Group 13-06-2022
Annual results 2021 / 2022 08-06-2022
Execution of an investment agreement and contribution in kind of a controlling stake by Pléiade Investissement to New Gen Holding, leading to a proposed public tender offer [...] 25-05-2022
Appointment of consulting firm Farthouat Finance as independent expert in connection with New Gen Holding's proposed takeover bid followed, if necessary, by a squeeze-out, for the shares of Generix Group (GENX - FR0010501692) 12-05-2022
Generix Group announces the resumption of its listing as of April 26, 2022 25-04-2022
Generix, its Management, Pléiade Investissement and Montefiore Investment enter into exclusive negotiations with a view to concluding an investment 22-04-2022
Generix Group publishes today its revenues for the 2021/2022 fiscal year 22-04-2022
Acquisition of 100% of Generix Group Portugal 04-04-2022
Q3 2021/2022 revenues: €20.5 M, in line with latest forecasts New SaaS contracts Q3 2021/2022: €1.4 M 27-01-2022
Half-year 2021/2022 Results | EBITDA rate 13,5% 08-12-2021
François Théry joins the Generix Group Executive Committee as Chief Financial Officer 30-11-2021